|
In the NewsBloomberg Markets Read the article, Betting on India's Future As of 9/30/2008, the average annual total returns for the Matthews India Fund for the one-year and since inception (10/31/05) periods were -32.93% and 11.91%, respectively. All performance quoted in this report is past performance and is no guarantee of future results. Investment return and principal value will fluctuate with changing market conditions so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the return figures quoted. Returns would have been lower if certain of the Fund’s fees and expenses had not been waived. View the Fund’s most recent month-end performance » Annual Operating Expenses1 You should consider the investment objectives, risks, charges and expenses of the Matthews Asia Funds carefully before making an investment decision. A prospectus with this and other information about the Funds may be obtained by calling 800.789.ASIA or visiting www.matthewsasia.com. Please read the prospectus carefully before investing as it explains the risks associated with investing in international markets. Investing in international markets may involve additional risks, such as social and political instability, market illiquidity, exchange-rate fluctuations, a high level of volatility and limited regulation. In addition, single-country and sector funds may be subject to a higher degree of market risk than diversified funds because of concentration in a specific industry, sector or geographic location. As of 9/30/2008, the securities mentioned in the article comprised the portfolio of the following percentages: Sun Pharmaceutical Industries, Ltd. represented 5.1%, Glenmark Pharmaceuticals, Ltd. represented 3.8%, Reliance Communications, Ltd. represented 2.7%, and Dabur India Ltd. represented 5.1% of the Matthews India Fund assets, respectively. The Matthews India Fund holds no positions in Eli Lily & Co. or in ITC Ltd. View the complete holdings of the India Fund. The information contained in this article does not, in any way, constitute investment advice. It should not be assumed that any investment will be profitable or will equal the performance of the portfolios or any securities or any sectors mentioned herein. The information does not constitute a recommendation to buy or sell any securities mentioned. Matthews Asia Funds and PFPC Distributors, Inc. have no editorial control over the content, subject matter and timing of this article and are independent of Bloomberg Markets magazine. Matthews Asia Funds are distributed by PFPC Distributors, Inc. 1 Ratio has been restated to reflect current management and administrative and shareholder servicing fees expected to be incurred by the funds and paid to the advisor. Matthews Asia Funds do not charge 12b-1 fees. |
